Sushmita Banerjee1, Surupa Basu2, Shakil Akhtar3, Rajiv Sinha3, Ananda Sen4, Jayati Sengupta3. 1. Department of Pediatric Nephrology, Institute of Child Health, Kolkata, India. asban444@gmail.com. 2. Department of Biochemistry, Institute of Child Health, Kolkata, India. 3. Department of Pediatric Nephrology, Institute of Child Health, Kolkata, India. 4. Department of Family Medicine and Biostatistics, University of Michigan, Ann Arbor, USA.
Abstract
INTRODUCTION: Body stores of vitamin D are measured as "total" serum 25-hydroxy vitamin D (25(OH)D). Its largest component is protein bound and lost in urine in nephrotic syndrome (NS). Our study investigates whether "free" 25(OH)D levels are a better guide to bone health and need for vitamin D supplementation in patients with steroid-sensitive NS (SSNS). METHODS: A cross-sectional study was performed in children with SSNS and healthy controls. Blood was tested for albumin, creatinine, calcium, phosphate, ALP, total and free (by direct ELISA) 25(OH)D, iPTH, and urine for protein-creatinine ratio. RESULTS: Seventy-nine NS patients (48 in relapse, 31 in remission) and 60 healthy controls were included. The levels of total 25(OH)D were significantly different (lowest in NS relapse and highest in controls) (p < 0.001). Corrected calcium and phosphate levels were normal, and there were no differences in free 25(OH)D, ALP, or iPTH levels between groups. Only total and not free 25(OH)D correlated significantly and negatively with urinary protein creatinine ratios (rs = - 0.42 vs. 0.04). Free 25(OH)D values of 3.75 and 2.85 pg/ml corresponded to total 25(OH)D levels of 20 and 12 ng/ml, respectively, in healthy controls. CONCLUSION: These results confirm that total 25(OH)D levels are low in NS and related to degree of proteinuria. However levels of free 25(OH)D, ALP, and iPTH did not change in relapse or remission in comparison with healthy controls. Our results suggest that in proteinuric renal diseases, free 25(OH)D rather than total 25(OH)D levels should be used to diagnose vitamin D deficiency and guide therapy.
INTRODUCTION: Body stores of vitamin D are measured as "total" serum 25-hydroxy vitamin D (25(OH)D). Its largest component is protein bound and lost in urine in nephrotic syndrome (NS). Our study investigates whether "free" 25(OH)D levels are a better guide to bone health and need for vitamin D supplementation in patients with steroid-sensitive NS (SSNS). METHODS: A cross-sectional study was performed in children with SSNS and healthy controls. Blood was tested for albumin, creatinine, calcium, phosphate, ALP, total and free (by direct ELISA) 25(OH)D, iPTH, and urine for protein-creatinine ratio. RESULTS: Seventy-nine NSpatients (48 in relapse, 31 in remission) and 60 healthy controls were included. The levels of total 25(OH)D were significantly different (lowest in NS relapse and highest in controls) (p < 0.001). Corrected calcium and phosphate levels were normal, and there were no differences in free 25(OH)D, ALP, or iPTH levels between groups. Only total and not free 25(OH)D correlated significantly and negatively with urinary protein creatinine ratios (rs = - 0.42 vs. 0.04). Free 25(OH)D values of 3.75 and 2.85 pg/ml corresponded to total 25(OH)D levels of 20 and 12 ng/ml, respectively, in healthy controls. CONCLUSION: These results confirm that total 25(OH)D levels are low in NS and related to degree of proteinuria. However levels of free 25(OH)D, ALP, and iPTH did not change in relapse or remission in comparison with healthy controls. Our results suggest that in proteinuric renal diseases, free 25(OH)D rather than total 25(OH)D levels should be used to diagnose vitamin D deficiency and guide therapy.
Authors: Jaya Sujatha Gopal-Kothandapani; Lucy Faith Evans; Jennifer S Walsh; Fatma Gossiel; Alan S Rigby; Richard Eastell; Nick J Bishop Journal: Clin Endocrinol (Oxf) Date: 2018-09-09 Impact factor: 3.478
Authors: Roger Bouillon; Claudio Marcocci; Geert Carmeliet; Daniel Bikle; John H White; Bess Dawson-Hughes; Paul Lips; Craig F Munns; Marise Lazaretti-Castro; Andrea Giustina; John Bilezikian Journal: Endocr Rev Date: 2019-08-01 Impact factor: 19.871
Authors: Francis L Weng; Justine Shults; Rita M Herskovitz; Babette S Zemel; Mary B Leonard Journal: Pediatr Nephrol Date: 2004-11-25 Impact factor: 3.714
Authors: Judith M A Emmen; Jos P M Wielders; Arjen-Kars Boer; Johannes M W van den Ouweland; Huib L Vader Journal: Clin Chem Lab Med Date: 2012-11 Impact factor: 3.694
Authors: Francisco Javier Turrubiates-Hernández; Gabriela Athziri Sánchez-Zuno; Guillermo González-Estevez; Jorge Hernández-Bello; Gabriela Macedo-Ojeda; José Francisco Muñoz-Valle Journal: Int J Mol Med Date: 2021-02-04 Impact factor: 4.101